News
The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...
Professor Lene Oddershede Chief Scientific Officer, Planetary Science & Technology at the Novo Nordisk Foundation talks about the applications of quantum computing at the tech disruptors podcast. She ...
The Novo Nordisk Foundation, top shareholder of Danish obesity drugmaker Novo Nordisk, plans to give a larger portion of its social, scientific and humanitarian grants outside of Denmark, a ...
LONDON (Reuters) - The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded foreign aid, and will continue to focus on its core ...
The Novo Nordisk Foundation is now the world’s wealthiest grant maker, with more than $114 billion in assets. That’s more than the combined endowments of the Bill & Melinda Gates Foundation, which ...
Novo Nordisk Foundation's nine-person board includes former Novo CEO and current board chairman Lars Rebien Sørensen, University of Copenhagen professor Liselotte Højgaard, Massachusetts ...
The Novo Nordisk Foundation, the philanthropic fund behind the maker of blockbuster drugs Ozempic and Wegovy, will give more donations to stem-cell based therapies as part of a shift in its focus ...
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback